PMID- 34174799 OWN - NLM STAT- MEDLINE DCOM- 20221130 LR - 20221130 IS - 1303-6165 (Electronic) IS - 1300-0144 (Linking) VI - 51 IP - 5 DP - 2021 Oct TI - Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis. PG - 2570-2574 LID - 10.3906/sag-2101-348 [doi] AB - BACKGROUND: Ganglioside antibodies are identified not only in patients with inflammatory neuropathies but also several central nervous system disorders and paraneoplastic neuropathies. Our aim was to investigate whether ganglioside antibodies are found in autoimmune encephalitis patients and may function as a diagnostic and prognostic biomarker. METHODS: Sera and cerebrospinal fluid (CSF) samples of 33 patients fulfilling the criteria for probable autoimmune encephalitis were collected within the first week of clinical manifestation. None of the patients had evident symptoms and findings of peripheral polyneuropathy. Well-characterized antineuronal and paraneoplastic antibodies were investigated in sera and CSF and antiganglioside (antiGM1, GM2, GM3, GD1a, GD1b, GT1b, and GQ1b) IgG and IgM antibodies were measured in sera using commercial immunoblots. RESULTS: Twenty-eight of 33 autoimmune encephalitis patients displayed antibodies against neuronal surface or onco-neural antigens with N-methyl-D-aspartate receptor (NMDAR), glutamic acid decarboxylase (GAD) and Hu antibodies being the most prevalent. While no antiganglioside IgG antibodies were found, 4 patients (2 anti-NMDAR+, 1 anti-GAD+ and 1 antibody negative) with autoimmune limbic encephalitis displayed anti-GM1, anti-GM2, anti-GM3 or anti-GQ1b IgM antibodies. There was no apparent association between antiganglioside positivity and clinical and demographic features. DISCUSSION: Serum ganglioside IgM antibodies may infrequently emerge during the clinical course of autoimmune limbic encephalitis without evident polyneuropathy. Absence of the IgG response suggests that these antibodies might have developed as a hyperacute immune response to neuro-axonal destruction. Nevertheless, potential impact of ganglioside antibodies on axonal degeneration and neuronal loss in limbic encephalitis pends to be further investigated. FAU - Oktar, Ayla Culha AU - Oktar AC AD - Department of Neurology, Haseki Training and Research Hospital, Istanbul, Turkey. FAU - Selcuk, Ozlem AU - Selcuk O AD - Department of Neurology, Haseki Training and Research Hospital, Istanbul, Turkey. FAU - Tunc, Cansu Elmas AU - Tunc CE AD - Department of Neurology, Haseki Training and Research Hospital, Istanbul, Turkey. FAU - Isildak, Senol AU - Isildak S AD - Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. FAU - Sanli, Elif AU - Sanli E AD - Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. FAU - Yilmaz, Vuslat AU - Yilmaz V AD - Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. FAU - Tuzun, Birgul Bastan AU - Tuzun BB AD - Department of Neurology, Haseki Training and Research Hospital, Istanbul, Turkey. FAU - Kurtuncu, Murat AU - Kurtuncu M AD - Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. FAU - Cokar, Ayse Ozlem AU - Cokar AO AD - Department of Neurology, Haseki Training and Research Hospital, Istanbul, Turkey. FAU - Tuzun, Erdem AU - Tuzun E AD - Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. LA - eng PT - Journal Article DEP - 20211021 PL - Turkey TA - Turk J Med Sci JT - Turkish journal of medical sciences JID - 9441758 RN - 0 (Gangliosides) RN - 0 (Immunoglobulin M) RN - 0 (Immunoglobulin G) RN - Autoimmune limbic encephalitis SB - IM MH - Humans MH - *Limbic Encephalitis MH - Gangliosides MH - Immunoglobulin M MH - Immunoglobulin G MH - *Polyneuropathies OTO - NOTNLM OT - Ganglioside OT - antibody OT - autoimmune encephalitis OT - autoimmunity OT - paraneoplastic EDAT- 2021/06/28 06:00 MHDA- 2022/12/01 06:00 CRDT- 2021/06/27 00:08 PHST- 2021/01/28 00:00 [received] PHST- 2021/06/24 00:00 [accepted] PHST- 2021/06/28 06:00 [pubmed] PHST- 2022/12/01 06:00 [medline] PHST- 2021/06/27 00:08 [entrez] AID - 10.3906/sag-2101-348 [doi] PST - ppublish SO - Turk J Med Sci. 2021 Oct;51(5):2570-2574. doi: 10.3906/sag-2101-348. Epub 2021 Oct 21.